Publications

• Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
  Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
  11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
• Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
  Bone Marrow Transplant Volume: 58 Page(s): 1264 - 1266
  11/01/2023 Authors: Raghunandan S; Qayed M; Watkins BK; Graiser M; Gorfinkel L; Westbrook A; Gillespie S; Bratrude B; Petrovic A; Suessmuth Y
• Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
  Blood Adv Volume: 7 Page(s): 4395 - 4399
  08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
• STEROID-ASSOCIATED ADVERSE EVENTS ARE DOSE-DEPENDENT FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION
  Volume: 70 Page(s): S213 - S213
  06/01/2023 Authors: Lisac R; Raghunandan S; Gillespie S; Liu K; Qayed M; Williams K; Watkins B
• Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
  Blood Adv Volume: 7 Page(s): 2196 - 2205
  05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Overlap chronic graft-versus-host disease (GvHD) is associated aith an adverse prognosis: secondary analysis of the ABA2 trial
  Volume: 57 Page(s): 41 - 41
  11/01/2022 Authors: Gorfinkel L; Raghunandan S; Langston A; Westbrook A; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C
• BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• ABATACEPT FOR THE PREVENTION OF GVHD IN PEDIATRIC PATIENTS RECEIVING 7/8 HLA-MISMATCHED TRANSPLANT
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Betz K; Suessmuth Y; Gillespie S; Westbrook A; Williams K; Schoettler M; Langston A
• Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
  Pediatr Blood Cancer Volume: 69 Page(s): e29428
  03/01/2022 Authors: Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
• CRYPTIC t(6;11) KMT2A-REARRANGEMENT IN A CHILD WITH AML DETECTED BY NEXT GENERATION SEQUENCING
  Volume: 68 Page(s): S147 - S148
  06/01/2021 Authors: Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi A; Carter A; Raikar S